Skip to content

Advertisement

About

Genome Medicine is an open access journal publishing outstanding research in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. Our publication policy combines selection for broad interest and importance with a commitment to serving authors well.

Hospitable publishing process. Genome Medicine offers rapid evaluation and clear and continuous communication on the progress of your manuscript. Upon submission, our in-house editors work with carefully selected reviewers and where necessary our Editorial Board of leading international experts to ensure a high quality and constructive editorial and peer review process.

High visibility. All content is open access immediately on publication. Papers that are published in Genome Medicine are featured on our website with article-level metrics and promoted via press releases, blogs and social media.

Flexible formatting. To facilitate the submission process, we are flexible with regard to the format, style and length of initial submissions. If it is more convenient to the authors, manuscripts can be uploaded as a single PDF or a Microsoft Word file with high resolution figures, figure legends and supplemental information included. The cover letter is provided separately during the submission process. Journal-specific formatting is required only once manuscripts reach the later stages of the publication process.

Presubmission enquiries. Authors who are seeking editorial input on whether their manuscripts would be appropriate for Genome Medicine can send us a presubmission enquiry. Presubmission inquiries should include a title, an abstract and a cover letter explaining the significance of the advance and the potential interest to our readership. Authors can also include the full manuscript in its current format. All presubmission enquiries should be sent by e-mail to editorial@genomemedicine.com.

Co-submissions to other BMC ‘flagship’ journals. If a paper is potentially appropriate in scope for Genome Medicine and Genome Biology or BMC Biology authors have the opportunity to submit a manuscript for joint consideration at two of these journals at the same time. For a paper to be considered as a co-submission, authors should upload their manuscript to one of the two journals and note in their cover letter that they would like a co-consideration with the second journal. Each journal will evaluate the paper independently. If both journals decide to send the paper for review, the editors will select reviewers together for a peer review process that evaluates the manuscript for both journals, and will make independent decisions based on reviewers’ feedback. For any questions about co-submissions, please contact editorial@genomemedicine.com.

Aims and scope

Genome Medicine publishes research and reviews that describe important advances in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. Areas covered include, but are not limited to: precision medicine, novel methods and software, cancer genomics, disease genomics and epigenomics, immunogenomics, infectious disease, microbiome and systems medicine.

Open access

All articles published by Genome Medicine are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

As authors of articles published in Genome Medicine you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.

For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

Open access publishing is not without costs. Genome Medicine therefore levies an article-processing charge of £1780.00/$2785.00/€2270.00 for each article accepted for publication, plus VAT or local taxes where applicable.

If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.

BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.

Indexing services

All articles published in Genome Medicine are included in:

  • CAS
  • Citebase
  • Journal Citation Reports/Science Edition
  • MEDLINE
  • OAIster
  • PubMed
  • PubMed Central
  • Science Citation Index
  • SCImago
  • Scopus
  • SOCOLAR
  • Zetoc

The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.

Peer-review policy

Peer review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help Editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.

Genome Medicine operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.

Manuscripts submitted to Genome Medicine are assessed by our experienced in-house editorial team, who make all decisions based on extensive and rigorous peer review by academic experts who specialize in the manuscript topic. Editorial Board Members may provide advice on manuscripts submitted to the journal but are not involved in the final decisions.  The overall editorial responsibility for the journal is with the Chief Editor.

We aim to provide our readership with the highest quality research and information in genomic and post-genomic medicine, and will therefore focus on articles of general and outstanding interest. We welcome presubmission enquiries by email.

Editorial policies

All manuscripts submitted to Genome Medicine should adhere to BioMed Central's editorial policies.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Citing articles in Genome Medicine

Articles in Genome Medicine  should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Genome Med [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Genome Med 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Appeals and complaints

If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.

Why publish your article in Genome Medicine

High visibility

Genome Medicine's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. 

Speed of publication

Genome Medicine offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.

Flexibility

Online publication in Genome Medicine gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Genome Medicine are included in article alerts and regular email updates. Some may be highlighted on Genome Medicine’s pages and on the BioMed Central homepage.

In addition, articles published in Genome Medicine may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Genome Medicine. A list of articles recently press-released by journals published by BioMed Central is available here.

Copyright

As an author of an article published in Genome Medicine you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.

2017 Journal Metrics

Advertisement